{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:34:49Z","timestamp":1792611289410,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Jornal de Pediatria"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jped.2025.04.009","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:49:06Z","timestamp":1749160146000},"page":"101411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison between the safety of the HPV vaccine versus placebo: a systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4355-6455","authenticated-orcid":false,"given":"Swelen Aparecida dos","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1054-0329","authenticated-orcid":false,"given":"Mariane Yoshie","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4424-6857","authenticated-orcid":false,"given":"Pedro Henrique Gunha","family":"Basilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6989-7125","authenticated-orcid":false,"given":"Meire Ellen","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0174-4792","authenticated-orcid":false,"given":"Rafaela Climaco","family":"Juli\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7732-6429","authenticated-orcid":false,"given":"Nielson da Cunha","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5119-2896","authenticated-orcid":false,"given":"Davi Paula da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2004-5316","authenticated-orcid":false,"given":"Cl\u00e1udia Sirlene","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0373-2317","authenticated-orcid":false,"given":"Victor Horacio de Souza","family":"Costa-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3104-3946","authenticated-orcid":false,"given":"Izonete Cristina","family":"Guiloski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jped.2025.04.009_bib0001","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.drudis.2019.07.011","article-title":"Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins","volume":"24","author":"Almeida","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jped.2025.04.009_bib0002","doi-asserted-by":"crossref","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","article-title":"Biological and clinical aspects of HPV-related cancers","volume":"17","author":"Szymonowicz","year":"2020","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.jped.2025.04.009_bib0003","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/ijc.32491","article-title":"Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status","volume":"146","author":"Mpunga","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jped.2025.04.009_bib0004","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.3390\/cancers13235889","article-title":"Immunotherapy approaches in HPV-associated head and neck cancer","volume":"13","author":"Julian","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jped.2025.04.009_bib0005","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1002\/ski2.98","article-title":"Consideration of underlying immunodeficiency in refractory or recalcitrant warts: a review of the literature","volume":"2","author":"Zampella","year":"2022","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.jped.2025.04.009_bib0006","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/vaccines9121413","article-title":"Human Papillomavirus vaccine efficacy and effectiveness against cancer","volume":"9","author":"Kamolratanakul","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jped.2025.04.009_bib0007","article-title":"Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: a meta-analysis","volume":"11","author":"Guo","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.jped.2025.04.009_bib0008","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jncimonographs\/lgae026","article-title":"Human papillomavirus prophylactic vaccines: update on new vaccine development and implications for single-dose policy","volume":"2024","author":"Schuind","year":"2024","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jped.2025.04.009_bib0009","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/0971-5916.195023","article-title":"Current global status & impact of human papillomavirus vaccination: implications for India","volume":"144","author":"Sankaranarayanan","year":"2016","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jped.2025.04.009_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2019.11.039","article-title":"Human papillomavirus vaccine against cervical cancer: opportunity and challenge","volume":"471","author":"Wang","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jped.2025.04.009_bib0011","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.vaccine.2019.01.069","article-title":"Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: a randomized, phase 3, placebo-controlled study","volume":"37","author":"Mikamo","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jped.2025.04.009_bib0012","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bjid.2014.02.005","article-title":"Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review","volume":"18","author":"Gon\u00e7alves","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jped.2025.04.009_bib0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jped.2025.04.009_bib0015","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.vaccine.2018.12.030","article-title":"Safety of a quadrivalent human papillomavirus vaccine in a phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up","volume":"37","author":"Chen","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jped.2025.04.009_bib0016","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/21645515.2017.1403700","article-title":"Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age","volume":"14","author":"Moreira","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jped.2025.04.009_bib0017","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/ijc.28897","article-title":"Efficacy, immunogenicity and safety of the HPV-16\/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial: HPV-16\/18 AS04-adjuvanted vaccine in Chinese women","volume":"135","author":"Zhu","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jped.2025.04.009_bib0018","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/infdis\/jis619","article-title":"Safety and immunogenicity of human papillomavirus-16\/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-seronegative African girls and young women","volume":"207","author":"Sow","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jped.2025.04.009_bib0019","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1016\/j.vaccine.2012.02.079","article-title":"Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and females","volume":"30","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jped.2025.04.009_bib0020","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.4161\/hv.28702","article-title":"Immunogenicity and safety of the HPV-16\/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years: results from 2 randomized controlled trials","volume":"10","author":"Zhu","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jped.2025.04.009_bib0021","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/21645515.2015.1008877","article-title":"Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa","volume":"11","author":"Mugo","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jped.2025.04.009_bib0022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000253970.29190.5a","article-title":"Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial","volume":"26","author":"Reisinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jped.2025.04.009_bib0024","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/j.vaccine.2022.05.023","article-title":"Factors associated with caregivers\u2019 hesitancy to vaccinate children against influenza: a cross-sectional survey in China","volume":"40","author":"Lai","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jped.2025.04.009_bib0025","article-title":"Trends in human Papillomavirus vaccine safety concerns and adverse event reporting in the United States","volume":"4","author":"Sonawane","year":"2021","journal-title":"JAMA New Open"},{"key":"10.1016\/j.jped.2025.04.009_bib0026","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13643-019-0983-y","article-title":"Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports","volume":"9","author":"J\u00f8rgensen","year":"2020","journal-title":"Syst Rev"},{"issue":"9","key":"10.1016\/j.jped.2025.04.009_bib0027","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/14760584.2022.2098719","article-title":"Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis","volume":"21","author":"Sutton","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jped.2025.04.009_bib0028","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40780-017-0087-6","article-title":"Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies","volume":"3","author":"Ogawa","year":"2017","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.jped.2025.04.009_bib0029","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/vaccines9080939","article-title":"Nervous and muscular adverse events after COVID-19 vaccination: a systematic review and meta-analysis of clinical trials","volume":"9","author":"Chen","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jped.2025.04.009_bib0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmv.27304","article-title":"The comparative safety of human papillomavirus vaccines: a Bayesian network meta-analysis","volume":"94","author":"Huang","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jped.2025.04.009_bib0031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis","volume":"11","author":"Lu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jped.2025.04.009_bib0032","unstructured":"World Health Organization. Diphtheria, Pertussis, Tetanus vaccines information sheet. [Cited 2025 Apr 10]. Available from:https:\/\/www.who.int\/publications\/m\/item\/DTP-vaccine-rates-information-sheet"},{"key":"10.1016\/j.jped.2025.04.009_bib0033","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamapediatrics.2013.2745","article-title":"Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children","volume":"167","author":"Rowhani-Rahbar","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jped.2025.04.009_bib0034","first-page":"1779","article-title":"Safety and adverse events of prophylactic HPV vaccines among healthy women: a systematic review & meta-analysis","volume":"6","author":"Sangar","year":"2015","journal-title":"Int J Pharm Sci Res"},{"key":"10.1016\/j.jped.2025.04.009_bib0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.rpped.2015.02.006","article-title":"Safety of human papillomavirus 6, 11, 16 and 18 (recombinant): systematic review and meta-analysis]","volume":"33","author":"Coelho","year":"2015","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.jped.2025.04.009_bib0036","first-page":"265","article-title":"Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis","volume":"47","author":"Setiawan","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jped.2025.04.009_bib0037","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3802\/jgo.2011.22.2.67","article-title":"Human papillomavirus 16\/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women","volume":"22","author":"Kim","year":"2011","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jped.2025.04.009_bib0038","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial","volume":"373","author":"Mu\u00f1oz","year":"2009","journal-title":"Lancet"}],"container-title":["Jornal de Pediatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755725000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755725000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:22:48Z","timestamp":1780561368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021755725000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0021755725000890"],"URL":"https:\/\/doi.org\/10.1016\/j.jped.2025.04.009","relation":{},"ISSN":["0021-7557"],"issn-type":[{"value":"0021-7557","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison between the safety of the HPV vaccine versus placebo: a systematic review and meta-analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Jornal de Pediatria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jped.2025.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Pediatria.","name":"copyright","label":"Copyright"}],"article-number":"101411"}}